Pavani S

An organized and motivated individual, eager to utilize time management and organizational skills across diverse settings. Seeking entry-level opportunities to enhance abilities while contributing to company growth.

Certification of Seminar, BREAST CANCER A brief description about the Cancer and Detailed about the Treatment of Breast cancer. Treatment without surgical of breast the can be started by a drug-(ado-trastuzumab emtansine) Drug dosing, Drug dosage, side effects, Administration and general clinical information of drug. Detailed about the Mechanism of action of a drug and working of drug. Breast Cancer is representing a completely new way to treat HER2-Positive metastatic Breast Cancer.

• Date of Birth: 09/26/95
• Gender: female
• Marital Status: married
• Religion: Hindu

YOUTH IN ACTION (NGO) BEST COLLEGE COORDINATOR (2016)

SYNTHESIS OF CHALCONES & SYNTHESIS OF FLAVONES FROM CHALCONES, Study of Organic Chemistry and understanding about the synthesis of chalcones & flavones. Chalcones and flavones were found to exhibited in different kinds of pharmacological activity like tested Anti-microbial activity. After resulting Synthesis of Flavones from Chalcones by TLC method. All the products were characterized by H- NMR,IR, MASS spectra. Chalcones are well known intermediates for synthesizing various heterocyclic compounds and have been report's to exhibit variety of biological activities. Flavones are also heterocyclic compounds and these are vascular plants and occurred naturally. To synthesize chalcones and flavones. To tested the purity of compound by preliminary testes such as melting points, TLC and physical and chemical parameters. To confirm structures of the synthesized compounds by NMR,IR,MASS spectra. MAJOR PROJECT: DESIGN, FORMULATION AND OPTIMIZATION OF CHRONO MODULATED PULSATILE DRUG DELIVERY SYSTEM OF NEBIVOLOL, With the development of pharmaceutical industry technologies, the drug supply systems have attracted a growing interest in the past few days. Nowadays, the importance of pharmaceutical gallonic research has led to the development of a more efficient pharmaceutical system with an existing molecule, as a result of the introduction of new drugs due to the inherent hurdles in the drug discovery and development process. Traditionally, pharmaceutical supplies are intended to be derived from the gut's predictable general chemical or injection site. The Volt Controlled Release System shows a distinctive model of drug release. This study attempts to formulate and evaluate a time controlled Chrono modulated drug delivery system of Nebivolol. Nebivolol is a choice β1-receiver antagonist. The activation of β1-receptors via epinephrine increases the heart rate and blood pressure and the heart uses more oxygen. Nebivolol prevents these receptors, preventing the effect of epinephrine, which reduces the heart rate and blood pressure. In addition, beta blockers prevent the release of renin, which is the hormone that produces kidneys that lead to the contraction of blood vessels. In high doses, this drug can also be beta 2 receptors. Nebivolol is highly protein-bound, mostly to albumin at 98%, independent of its concentrations. Hepatic (CYP2D6-mediated) The development and characterization of nebivolol pulsatile tablets is developed by using synthetic polymers such as ethyl cellulose and sodium alginate were used. The talc, magnesium sterate, mcc were used. The tablets were prepared by the direct compression method.

• ICD-10
• CPT
• HCPCS